Nonadherence to oral mercaptopurine and risk of relapse in Hispanic and non-Hispanic white children with acute lymphoblastic leukemia: a report from the children's oncology group. - Wikidata - wikimedia - TriplyDB

Nonadherence to oral mercaptopurine and risk of relapse in Hispanic and non-Hispanic white children with acute lymphoblastic leukemia: a report from the children's oncology group.

Nonadherence to oral mercaptopurine and risk of relapse in Hispanic and non-Hispanic white children with acute lymphoblastic leukemia: a report from the children's oncology group.

http://www.wikidata.org/entity/Q36695870

about

Acute lymphoblastic leukaemia Best Practices in Adolescent and Young Adult Patients with Acute Lymphoblastic Leukemia: A Focus on Asparaginase Mercaptopurine/Methotrexate maintenance therapy of childhood acute lymphoblastic leukemia: clinical facts and fiction Activating mutations in the NT5C2 nucleotidase gene drive chemotherapy resistance in relapsed ALL.Does vaccine dose predict response to the monovalent pandemic H1N1 influenza a vaccine in children with acute lymphoblastic leukemia? A single-centre study.Genomics of racial and ethnic disparities in childhood acute lymphoblastic leukemia.Commentary: demonstrating cost-effectiveness in pediatric psychology Inclusion of Adolescents and Young Adults in Cancer Clinical Trials.6MP adherence in a multiracial cohort of children with acute lymphoblastic leukemia: a Children's Oncology Group study Inherited NUDT15 variant is a genetic determinant of mercaptopurine intolerance in children with acute lymphoblastic leukemia.The Initiative to Maximize Progress in Adolescent and Young Adult Cancer Therapy (IMPACT) Cohort Study: a population-based cohort of young Canadians with cancer.Augmented Berlin-Frankfurt-Münster therapy in adolescents and young adults (AYAs) with acute lymphoblastic leukemia (ALL).Electronic monitoring of medication adherence in early maintenance phase treatment for pediatric leukemia and lymphoma: identifying patterns of nonadherence Low socioeconomic status is associated with worse survival in children with cancer: a systematic review Threading the cloak: palliative care education for care providers of adolescents and young adults with cancer Treatment of pediatric acute lymphoblastic leukemia.Survival of Mexican Children with Acute Lymphoblastic Leukaemia under Treatment with the Protocol from the Dana-Farber Cancer Institute 00-01 Systemic Exposure to Thiopurines and Risk of Relapse in Children With Acute Lymphoblastic Leukemia: A Children's Oncology Group Study.Pediatric acute lymphoblastic leukemia: where are we going and how do we get there?Thiopurine methyltransferase and treatment outcome in the UK acute lymphoblastic leukaemia trial ALL2003.Medication adherence decision-making among adolescents and young adults with cancer Thiopurine dose intensity and treatment outcome in childhood lymphoblastic leukaemia: the influence of thiopurine methyltransferase pharmacogenetics.Leveraging epidemiology and clinical studies of cancer outcomes: recommendations and opportunities for translational research Protecting pediatric oncology patients from influenza Thiopurine methyltransferase genotype-phenotype discordance and thiopurine active metabolite formation in childhood acute lymphoblastic leukaemia.The adolescent and young adult with cancer: state of the art-- acute leukemias.A 50-year journey to cure childhood acute lymphoblastic leukemia Children's Oncology Group's 2013 blueprint for research: survivorship and outcomes.Improving adherence to oral cancer therapy in clinical practice.Facilitators and Barriers to Self-Management for Adolescents and Young Adults Following a Hematopoietic Stem Cell Transplant.Assessing Medication Adherence as a Standard of Care in Pediatric Oncology.Culture, Styles of Institutional Interactions, and Inequalities in Healthcare Experiences.Next steps for adolescent and young adult oncology workshop: An update on progress and recommendations for the future.Longitudinal Patterns of Medication Nonadherence and Associated Health Care Costs.Mercaptopurine Ingestion Habits, Red Cell Thioguanine Nucleotide Levels, and Relapse Risk in Children With Acute Lymphoblastic Leukemia: A Report From the Children's Oncology Group Study AALL03N1.National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Patient-Centered Outcomes Working Group Report.Oral Chemotherapy in Patients with Hematological Malignancies-Care Process, Pharmacoeconomic and Policy Implications.Errors and Nonadherence in Pediatric Oral Chemotherapy Use.Bending the Cost Curve in Childhood Cancer.Scientific Achievements May Not Reach Everyone: Understanding Disparities in Acute Leukemia.

P2860

Q24602387-0D2963D9-2322-4EFD-9455-B5DA48C54954 Q26784116-FAC900D0-4045-460C-B3A6-B1D5B33ED45C Q27023839-939B32D1-E341-4A9A-B3A0-0B5A6BA8B5BE Q27852067-C3D078F7-8B48-429C-B5AE-07AF0103EC5A Q30430658-F0AADD56-29A5-4B24-8453-A90CBDF07B6D Q33586588-A12127ED-B2B5-4763-8222-8543C5653418 Q33771215-3C03A3F4-4A67-4AAB-9149-9E3034225A93 Q33922505-0D1B6979-9DDE-43C6-824D-D03C51C6BD40 Q34318474-F52B8D7C-49DA-4E0D-B89C-219BCEEF549E Q34459885-2EF75D96-74A7-437A-8695-597C79EFEE9D Q34491288-D7DE367E-BC74-4623-BE1E-92B7154E0D20 Q34550540-38050821-1D40-446D-AD18-10F9D039470D Q34884871-AD5DE392-8778-4386-9A88-ABB02C9FE4C1 Q35107431-3FC8755B-1AE8-42FD-BC06-930A8883EE4C Q35148951-68ECE490-86AE-4045-9C9E-E56633E047BE Q35196702-23A90BFB-7EE0-49CC-A5F5-B710DCE871A4 Q35437903-AC0B3282-D005-4820-A977-FA68877574FB Q36031471-37D6A693-E083-4714-8368-8D38B65D1779 Q36163029-E9D6CE8F-2B91-4EDA-8661-824C98EF1828 Q36393968-687655AE-755F-4283-988C-9BA876E7264E Q36446637-EB58315C-E9BF-4FA0-89B6-10E8EBAAE67F Q36532537-AE568FC9-3072-43D7-9B1F-CF727AA4433A Q36535678-980843BE-0A4F-4AF9-9BB4-CE57CC113E7B Q36630470-D44BDC13-5A0D-4428-A937-80550248ACFB Q36988021-1367ED0B-504D-4AFA-8887-BD6D064270E0 Q37134753-D3745C32-7AAB-452E-BCDB-CCD83ADB5B81 Q37166753-D9CC7E92-0719-4731-AFBA-7B0EEB287706 Q37237505-6DCF8BFB-87F1-40DF-81EC-1B70CC7840E5 Q38216035-EFE0A479-6355-4D12-8A65-7E1E99C8AD30 Q38635342-E5E2FCE0-178D-4773-9429-567CE55AF725 Q38678323-1FA899BC-F369-4C42-9685-04886BB6C422 Q38702545-B83BFD5D-0F4E-4BBB-B081-73346B96504E Q38724079-1D6EB821-43AB-4B20-B1A7-1FCE7B44D9FB Q38724407-D8C3A599-B861-4009-8C81-76A4145BF904 Q38740338-36DDA64F-1E17-4498-9BAA-313814E3EEA8 Q38808511-538E6785-6F64-4D2B-8D7E-F9FF2A766890 Q38810189-515954E0-D324-448D-AB26-2F76C9154CBA Q38834936-5F615AC7-794A-446B-8E2F-02A6C347A402 Q38837762-8058697D-111D-4BA2-8242-88AC28C060D1 Q38840936-3C66A371-3D2C-4D16-A7DE-AED47ADBAFAA

P2860

Nonadherence to oral mercaptopurine and risk of relapse in Hispanic and non-Hispanic white children with acute lymphoblastic leukemia: a report from the children's oncology group.

http://www.wikidata.org/entity/Q36695870

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Nonadherence to oral mercaptop ...... the children's oncology group.

@ast

Nonadherence to oral mercaptop ...... the children's oncology group.

@en

type

label

Nonadherence to oral mercaptop ...... the children's oncology group.

@ast

Nonadherence to oral mercaptop ...... the children's oncology group.

@en

prefLabel

Nonadherence to oral mercaptop ...... the children's oncology group.

@ast

Nonadherence to oral mercaptop ...... the children's oncology group.

@en

P1433

Q36695870-1D6846FF-7CC7-4453-BEEC-80E424AB08F8

P1476

Q36695870-9137C6AC-8C6B-48BA-AC3A-8C444233A92B

P2093

Q36695870-0332BD3E-92DF-4EF6-82B6-3C367CF423F1

Q36695870-0AEE631A-7582-4C6B-ABFE-D6DC95E01619

Q36695870-0C110AD9-76A4-4DB5-A83C-474A7BECA340

Q36695870-26AC9C30-A6D4-431A-9253-425A4695F4B5

Q36695870-27CC5D9F-D897-46F5-83E7-BC4D6FB1C33E

Q36695870-492C20AA-7346-421E-B66F-9B206EB1C013

Q36695870-5A15677F-730E-409D-8518-0B1B78D8E42A

Q36695870-63E6F6C3-EDF8-4293-A01A-E72BC6258112

Q36695870-7BCCC5D8-6B90-47F7-8F12-DCD9C942C258

Q36695870-86FF3068-2C05-41EC-96A7-1B51031AAF69

P2860

Q36695870-23DB7499-E121-4EA1-9092-911250B5B5A5

Q36695870-303B21AA-FE41-414B-A861-DD69CF689BDA

Q36695870-33B83549-5DB8-48EB-9AB9-6D68F82586A5

Q36695870-34E54139-549F-4298-AAB0-405949CF357B

Q36695870-405186A4-0E67-4FA2-866A-EEA183BE6EF0

Q36695870-52B2F82E-3DDD-4731-9B4C-61C9B4931E2C

Q36695870-5C0793EE-4E2E-4AAE-AAA3-2CB1052F14F5

Q36695870-63CD5EA4-ED46-4501-8EB4-7473662145E0

Q36695870-686CF272-816F-4234-A098-56436EFDEABE

Q36695870-6C264BF1-611E-498C-9834-6D2FCD1B7EEA

P304

Q36695870-1A25DC5D-335D-40AA-AC81-9ED008733A73

P31

Q36695870-1C431AA8-0F76-4351-855D-41D4C6CF8AE1

P356

Q36695870-43EA5A61-9C8A-459A-A165-7EF14139FD80

P407

Q36695870-68A80CFE-3BD4-41BA-B3EA-7F5867484D56

P433

Q36695870-3148AF23-B492-40F8-A193-6A5FA34E8141

P478

Q36695870-B9DAF709-E1A8-44E1-9001-841F4E153674

P50

Q36695870-4A61B3C6-1850-48BA-A619-020C00EBB17B

P577

Q36695870-C93F8A58-B425-48CA-B2EC-AD318E0C407D

P698

Q36695870-A38058DC-2E98-4A95-9DB3-752D231A5DE6

P932

Q36695870-5C0A57EF-9875-4B6A-8E68-13A500D0A61C

P356

JCO.2011.38.9924

P1433

Journal of Clinical Oncology

P1476

Nonadherence to oral mercaptop ...... the children's oncology group.

@en

P2093

A Kim Ritchey

http://www.w3.org/2001/XMLSchema#string

Alexandra N Schaible

http://www.w3.org/2001/XMLSchema#string

Andrea R Carter

http://www.w3.org/2001/XMLSchema#string

Cara L Hanby

http://www.w3.org/2001/XMLSchema#string

David S Dickens

http://www.w3.org/2001/XMLSchema#string

F Lennie Wong

http://www.w3.org/2001/XMLSchema#string

Jacqueline N Casillas

http://www.w3.org/2001/XMLSchema#string

Jane Meza

http://www.w3.org/2001/XMLSchema#string

Leo Mascarenhas

http://www.w3.org/2001/XMLSchema#string

Lindsey Hageman

http://www.w3.org/2001/XMLSchema#string

P2860

Adherence to Medication

Racial differences in long-term adherence to oral antidiabetic drug therapy: a longitudinal cohort study.

Estimation of failure probabilities in the presence of competing risks: new representations of old estimators.

Mercaptopurine therapy intolerance and heterozygosity at the thiopurine S-methyltransferase gene locus.

Rearrangement of CRLF2 is associated with mutation of JAK kinases, alteration of IKZF1, Hispanic/Latino ethnicity, and a poor outcome in pediatric B-progenitor acute lymphoblastic leukemia

A review of adjusted estimators of attributable risk.

Cytogenetics in acute leukemia.

How often is medication taken as prescribed? A novel assessment technique.

Ancestry and pharmacogenomics of relapse in acute lymphoblastic leukemia.

Variable mercaptopurine metabolism in children with leukaemia: a problem of non-compliance?

P304

2094-2101

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1200/JCO.2011.38.9924

http://www.w3.org/2001/XMLSchema#string

P407

P433

17

http://www.w3.org/2001/XMLSchema#string

P478

30

http://www.w3.org/2001/XMLSchema#string

P50

Wendy Leisenring

P577

2012-05-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22564992

http://www.w3.org/2001/XMLSchema#string

P932

3601449

http://www.w3.org/2001/XMLSchema#string